| Product NDC: | 45802-076 |
| Proprietary Name: | Imiquimod |
| Non Proprietary Name: | imiquimod |
| Active Ingredient(s): | 50 mg/1000mg & nbsp; imiquimod |
| Administration Route(s): | TOPICAL |
| Dosage Form(s): | CREAM |
| Coding System: | National Drug Codes(NDC) |
| Product NDC: | 45802-076 |
| Labeler Name: | Perrigo New York Inc. |
| Product Type: | HUMAN PRESCRIPTION DRUG |
| FDA Application Number: | NDA020723 |
| Marketing Category: | NDA |
| Start Marketing Date: | 20100420 |
| Package NDC: | 45802-076-62 |
| Package Description: | 24 PACKET in 1 CARTON (45802-076-62) > 250 mg in 1 PACKET (45802-076-00) |
| NDC Code | 45802-076-62 |
| Proprietary Name | Imiquimod |
| Package Description | 24 PACKET in 1 CARTON (45802-076-62) > 250 mg in 1 PACKET (45802-076-00) |
| Product NDC | 45802-076 |
| Product Type Name | HUMAN PRESCRIPTION DRUG |
| Non Proprietary Name | imiquimod |
| Dosage Form Name | CREAM |
| Route Name | TOPICAL |
| Start Marketing Date | 20100420 |
| Marketing Category Name | NDA |
| Labeler Name | Perrigo New York Inc. |
| Substance Name | IMIQUIMOD |
| Strength Number | 50 |
| Strength Unit | mg/1000mg |
| Pharmaceutical Classes | Increased Cytokine Activity [PE],Increased Cytokine Production [PE],Interferon Inducers [MoA] |